Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiation dose estimates for C-11 iomazenil, a benzodiazepine receptor radioligand

Journal Article · · Journal of Nuclear Medicine
OSTI ID:198018
; ;  [1]
  1. Oak Ridge Institute for Science and Education, TN (United States); and others

SPECT imaging of the brain with I-123 iomazenil has shown avid uptake of the radioligand in a distribution consistent with benzodiazepine receptor binding. It was desirable to radiolabel this compound with a positron emitting radionuclide so that quantitation of the receptor density could be assessed with PET imaging. Radiation dose estimates for C-11 iomazenil were calculated prior to obtaining Institutional Review Board approval of this procedure. A previously published multicompartmental model was used as the biological model for estimating residence times associated with the C-11 labeled iomazenil. According to this model, 85-90% is excreted in the urine and 10-15% in the feces. A dynamic, voiding urinary bladder model was utilized for activity excreted renally and the ICRP 30 gastrointestinal tract kinetic model was used for activity excreted via the hepatobiliary system. Absorbed doses from C-11 (I-123) iomazenil to the urinary bladder were calculated to be 0.099 mGy/MBq (0.19 mGy/MBq) for a 4.8 hour bladder voiding interval. Shortening the bladder voiding interval to 2.0 hours had little effect on the bladder wall dose (0.095 mGy/MBq). However, a 30-minute void interval was estimated to lower the bladder wall dose substantially (0.045 mGy/MBq). Absorbed dose to the kidney was higher for C-11 iomazenil (0.054 vs 0.031 mGy/MBq) than for I-123 iomazenil due to rapid, early renal excretion of this very short-lived positron emitter. Doses to the gastrointestinal tract were estimated to be 4- to 20-fold lower for C-11 iomazenil compared to I-123 iomazenil. Overall, labeling iomazenil with C-11 rather than I-123 greatly reduces the radiation dose, per unit administered, to all organs except the kidneys.

OSTI ID:
198018
Report Number(s):
CONF-940605--
Journal Information:
Journal of Nuclear Medicine, Journal Name: Journal of Nuclear Medicine Journal Issue: Suppl.5 Vol. 35; ISSN JNMEAQ; ISSN 0161-5505
Country of Publication:
United States
Language:
English

Similar Records

Human biodistribution and dosimetry of the SPECT benzodiazepine receptor radioligand iodine-123-iomazenil
Journal Article · Mon Feb 28 23:00:00 EST 1994 · Journal of Nuclear Medicine Technology · OSTI ID:135830

The radiation dosimetry of In-111 pentetreotide
Journal Article · Mon May 01 00:00:00 EDT 1995 · Journal of Nuclear Medicine · OSTI ID:441635

Compartmental modeling of and radiation dose estimates for {sup 186}Re NR-LU-10 monoclonal antibody
Journal Article · Sun May 01 00:00:00 EDT 1994 · Journal of Nuclear Medicine · OSTI ID:198014